Evidence map›Paper›PMID 38781157›Full record

ArticlePloS one2024

Molecular regulation of PPARγ/RXRα signaling by the novel cofactor ZFP407.

Alyssa Charrier, Jeremiah Ockunzzi, Leighanne Main, Siddharth V Ghanta, David A Buchner

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alyssa CharrierDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America.
Jeremiah OckunzziDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America.ORCID 0009-0002-2935-4518
Leighanne MainDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America.
Siddharth V GhantaDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America.
David A BuchnerDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America.ORCID 0000-0003-3920-4871

Funding

The Alzheimer Disease Sequence Analysis CollaborativeU01AG058654 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI BUSH, WILLIAM S, FARRER, LINDSAY A. · 2018 to 2022
$14.6M
Protective Genetic Varients for Alzheimer Disease in the AmishR01AG058066 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI Jonathan L Haines, Margaret A. Pericak-Vance · 2022 to 2026
$8.0M
Role of adipocyte gene expression regulation by Zfp407 in adipocyte biology and metabolic diseaseR01DK119305 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI BUCHNER, DAVID A · 2019 to 2023
$2.0M
The Alzheimer's Disease Translational Data Science Training ProgramT32AG071474 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI BUSH, WILLIAM S · 2021 to 2025
$1.1M
NIA NIH HHS R01 AG058066NIA NIH HHS T32 AG071474NIA NIH HHS U01 AG058654NIDDK NIH HHS R01 DK119305
6 · The paper itself

Abstract

Cofactors interacting with PPARγ can regulate adipogenesis and adipocyte metabolism by modulating the transcriptional activity and selectivity of PPARγ signaling. ZFP407 was previously demonstrated to regulate PPARγ target genes such as GLUT4, and its overexpression improved glucose homeostasis in mice. Here, using a series of molecular assays, including protein-interaction studies, mutagenesis, and ChIP-seq, ZFP407 was found to interact with the PPARγ/RXRα protein complex in the nucleus of adipocytes. Consistent with this observation, ZFP407 ChIP-seq peaks significantly overlapped with PPARγ ChIP-seq peaks, with more than half of ZFP407 peaks overlapping with PPARγ peaks. Transcription factor binding motifs enriched in these overlapping sites included CTCF, RARα/RXRγ, TP73, and ELK1, which regulate cellular development and function within adipocytes. Site-directed mutagenesis of frequent PPARγ phosphorylation or SUMOylation sites did not prevent its regulation by ZFP407, while mutagenesis of ZFP407 domains potentially necessary for RXR and PPARγ binding abrogated any impact of ZFP407 on PPARγ activity. These data suggest that ZFP407 controls the activity of PPARγ, but does so independently of post-translational modifications, likely by direct binding, establishing ZFP407 as a newly identified PPARγ cofactor. In addition, ZFP407 ChIP-seq analyses identified regions that did not overlap with PPARγ peaks. These non-overlapping peaks were significantly enriched for the transcription factor binding motifs of TBX19, PAX8, HSF4, and ZKSCAN3, which may contribute to the PPARγ-independent functions of ZFP407 in adipocytes and other cell types.

Indexed as

AdipocytesPPAR gammaRetinoid X Receptor alphaSignal Transduction3T3-L1 CellsAnimalsBinding SitesDNA-Binding ProteinsHumansMicePhosphorylationProtein BindingSumoylationTranscription FactorsDNA-Binding ProteinsPPAR gammaPparg protein, mouseRetinoid X Receptor alphaTranscription FactorsZNF407 protein, mouse

Identifiers

PMID38781157
PMCPMC11115250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.